Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 4
2009 2
2010 1
2011 4
2012 2
2013 3
2014 2
2016 3
2017 4
2018 4
2019 6
2020 12
2021 11
2022 18
2023 10
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Cosmetics Preservation: A Review on Present Strategies.
Halla N, Fernandes IP, Heleno SA, Costa P, Boucherit-Otmani Z, Boucherit K, Rodrigues AE, Ferreira ICFR, Barreiro MF. Halla N, et al. Among authors: fernandes ip. Molecules. 2018 Jun 28;23(7):1571. doi: 10.3390/molecules23071571. Molecules. 2018. PMID: 29958439 Free PMC article. Review.
Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial.
Vogelzang NJ, Beer TM, Gerritsen W, Oudard S, Wiechno P, Kukielka-Budny B, Samal V, Hajek J, Feyerabend S, Khoo V, Stenzl A, Csöszi T, Filipovic Z, Goncalves F, Prokhorov A, Cheung E, Hussain A, Sousa N, Bahl A, Hussain S, Fricke H, Kadlecova P, Scheiner T, Korolkiewicz RP, Bartunkova J, Spisek R; VIABLE Investigators. Vogelzang NJ, et al. JAMA Oncol. 2022 Apr 1;8(4):546-552. doi: 10.1001/jamaoncol.2021.7298. JAMA Oncol. 2022. PMID: 35142815 Free PMC article. Clinical Trial.
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.
Powles T, van der Heijden MS, Castellano D, Galsky MD, Loriot Y, Petrylak DP, Ogawa O, Park SH, Lee JL, De Giorgi U, Bögemann M, Bamias A, Eigl BJ, Gurney H, Mukherjee SD, Fradet Y, Skoneczna I, Tsiatas M, Novikov A, Suárez C, Fay AP, Duran I, Necchi A, Wildsmith S, He P, Angra N, Gupta AK, Levin W, Bellmunt J; DANUBE study investigators. Powles T, et al. Lancet Oncol. 2020 Dec;21(12):1574-1588. doi: 10.1016/S1470-2045(20)30541-6. Epub 2020 Sep 21. Lancet Oncol. 2020. PMID: 32971005 Clinical Trial.
Sarcoma Metabolomics: Current Horizons and Future Perspectives.
Esperança-Martins M, Fernandes I, Soares do Brito J, Macedo D, Vasques H, Serafim T, Costa L, Dias S. Esperança-Martins M, et al. Among authors: fernandes i. Cells. 2021 Jun 8;10(6):1432. doi: 10.3390/cells10061432. Cells. 2021. PMID: 34201149 Free PMC article. Review.
c-Met expression in renal cell carcinoma with bone metastases.
Silva Paiva R, Gomes I, Casimiro S, Fernandes I, Costa L. Silva Paiva R, et al. Among authors: fernandes i. J Bone Oncol. 2020 Sep 16;25:100315. doi: 10.1016/j.jbo.2020.100315. eCollection 2020 Dec. J Bone Oncol. 2020. PMID: 33024658 Free PMC article. Review.
On the Relevance of Soft Tissue Sarcomas Metabolic Landscape Mapping.
Esperança-Martins M, F Duarte I, Rodrigues M, Soares do Brito J, López-Presa D, Costa L, Fernandes I, Dias S. Esperança-Martins M, et al. Among authors: fernandes i. Int J Mol Sci. 2022 Sep 28;23(19):11430. doi: 10.3390/ijms231911430. Int J Mol Sci. 2022. PMID: 36232732 Free PMC article. Review.
86 results